Disclaimer: This information is intended for educational purposes only and should not be considered medical advice. It is crucial for clinicians to exercise independent medical judgment, consider individual patient circumstances, and consult with specialists as appropriate. This document does not replace direct patient contact, clinical experience, or the latest professional guidelines. Medical practice is constantly evolving, and information may become outdated.

---

Failure Of Induction Of Labor

Overview

Definition

Failure of induction of labor is defined as the inability to achieve regular uterine contractions and progressive cervical change (dilation and effacement) after an adequate trial of labor induction methods, including cervical ripening and oxytocin administration. This typically means failure to enter the active phase of labor.

Current consensus guidelines (ACOG/SMFM) define an adequate trial of labor induction as: * After cervical ripening (if needed): At least 12-18 hours of oxytocin administration. * After membrane rupture (spontaneous or artificial): At least 12-18 hours of oxytocin administration in patients with an unfavorable cervix, or 12-18 hours of oxytocin administration after cervical ripening if membranes are intact. * Overall duration: In some cases, a total induction period of 24-48 hours, encompassing both cervical ripening and oxytocin titration, may be considered an adequate trial before diagnosing failure. This allows sufficient time for various ripening agents and high-dose oxytocin protocols to take effect.

It is crucial to distinguish failure of induction (failure to enter active labor) from arrest of labor (failure to progress once in active labor). This reference focuses on the former.

Epidemiology

• Incidence: Varies widely, ranging from 15% to 25% of all induced labors. Higher rates are observed in nulliparous women, those with an unfavorable cervix at the start of induction, and those with certain risk factors.
• Demographics: Nulliparous women are at significantly higher risk compared to multiparous women (e.g., 2-3 times higher risk).
• Impact: Failure of induction is a leading indication for primary Cesarean delivery, contributing significantly to the overall C-section rate.

Classification

Failure of induction is not typically classified into subtypes. However, it can be viewed in the context of: * Stage of failure: * Failure of cervical ripening (inadequate Bishop score improvement). * Failure to establish regular, effective contractions despite adequate oxytocin. * Failure to transition from latent to active labor. * Contributing factor: * Maternal factors (e.g., uterine inertia, unfavorable cervix). * Fetal factors (e.g., malposition, macrosomia). * Combined factors.

Pathophysiology

Mechanism

The underlying mechanisms contributing to failure of induction are often multifactorial and include: * Uterine Inertia/Dysfunction: Inadequate uterine contractility despite oxytocin stimulation, resulting in insufficient force or frequency of contractions to effect cervical change. This may be due to myometrial resistance to oxytocin or underlying uterine abnormalities. * Unfavorable Cervix: A cervix that is not adequately "ripe" (effaced, dilated, soft, anterior) at the start of induction or fails to ripen adequately. This is often quantified by a low Bishop score. A rigid, posterior, closed cervix is resistant to the forces of labor. * Cephalopelvic Disproportion (CPD): A mismatch between the size of the fetal head and the maternal pelvis. While true CPD is rare, relative CPD (e.g., due to macrosomia or malposition) can prevent engagement and descent, leading to failed progression. * Fetal Malposition/Malpresentation: Non-optimal fetal position (e.g., persistent occiput posterior, asynclitism) can hinder engagement, descent, and effective pressure on the cervix. * Inadequate Induction Regimen: Suboptimal dosing or duration of cervical ripening agents or oxytocin. * Prior Uterine Surgery: History of uterine surgery (e.g., myomectomy, classical C-section) may influence uterine response to induction or increase rupture risk, leading to conservative induction protocols that may not be sufficiently potent.

Risk Factors

• Nulliparity: The strongest independent risk factor.
• Unfavorable Cervix (Low Bishop Score): A Bishop score of <6 at the onset of induction significantly increases the risk of failure.
• Obesity (BMI >30 kg/m²): Associated with longer induction times, higher oxytocin requirements, and increased rates of induction failure.
• Post-term Pregnancy (>41 weeks): May have less responsive cervices and larger fetuses.
• Large for Gestational Age (LGA) / Suspected Macrosomia: Increases the risk of CPD and malposition.
• Increased Maternal Age: Age >35-40 years.
• Pre-pregnancy Comorbidities: Such as chronic hypertension or diabetes.
• Chorioamnionitis (before or during induction): While often a complication, can also be a cause of uterine dysfunction.
• Premature Rupture of Membranes (PROM) at term: While often an indication for induction, it can be associated with increased rates of failed induction if labor does not spontaneously commence and the cervix is unfavorable.

Protective Factors

• Favorable Cervix (High Bishop Score): A Bishop score ≥8 is highly predictive of successful induction.
• Prior Vaginal Delivery: Multiparous women have a significantly higher success rate.
• Appropriate Fetal Size and Position: Non-macrosomic fetus in an occiput anterior position.
• Spontaneous Rupture of Membranes (SROM) during induction: Often accelerates labor.

Clinical Presentation

Signs and Symptoms

Failure of induction is primarily diagnosed by the absence of expected progress despite appropriate interventions. * Cardinal Features: * Absence of regular, strong uterine contractions (e.g., <3 contractions in 10 minutes, lasting <40 seconds, or <200 Montevideo units on internal monitoring) despite adequate oxytocin titration to maximal safe dose. * Lack of progressive cervical change (dilation and effacement) over several hours. * Early Signs: * Slow or no change in Bishop score after cervical ripening methods. * Inability to achieve adequate contraction pattern despite increasing oxytocin. * Prolonged latent phase (e.g., >18-24 hours for nulliparous, >14 hours for multiparous, often extended based on overall induction duration). * Advanced Signs: * No change in cervical dilation for ≥ 4-6 hours with adequate contractions and ruptured membranes (criteria for active phase arrest, but here applied to the definition of failed induction's final stages). * No descent of the fetal head. * Atypical Presentations: * Patient discomfort or pain disproportionate to cervical change (may suggest uterine dysfunction or malposition). * Non-reassuring fetal heart rate patterns in the absence of significant contractions (may suggest underlying fetal compromise, not directly a sign of failed induction but a complication requiring re-evaluation).

Physical Examination

Physical examination is crucial for monitoring progress and assessing the likelihood of success. * Inspection: * Observation of external fetal monitoring (cardiotocography) for uterine contraction frequency, duration, and intensity (qualitatively). * General maternal well-being (hydration, signs of fatigue). * Palpation: * Leopold's maneuvers: To confirm fetal presentation, position, and estimated fetal weight. * Uterine palpation: To assess contraction intensity and relaxation between contractions. * Fundal height: To estimate gestational age and fetal size. * Special Tests: * Vaginal Examination: The most critical assessment. Performed regularly (e.g., every 2-4 hours, or after change in oxytocin dose, or patient request) to assess: * Cervical Dilation: Measured in centimeters (cm). * Cervical Effacement: Measured in percentage (%). * Fetal Station: Relationship of the presenting part to the ischial spines (e.g., -3 to +3 cm). * Cervical Consistency: Soft, medium, firm. * Cervical Position: Anterior, mid-position, posterior. * Membrane Status: Intact or ruptured. * Bishop Score: A composite score (0-13) based on dilation, effacement, station, consistency, and position. A score ≥8 suggests a high likelihood of successful induction. * Internal Fetal Monitoring (IFM) with Intrauterine Pressure Catheter (IUPC): If external monitoring is inadequate or progress is stalled. Measures Montevideo Units (MVUs) to objectively assess contraction strength (MVUs = sum of peak amplitude of contractions above baseline in a 10-minute window). Adequate labor is typically associated with >200 MVUs.

Diagnostic Approach

History Taking

• Key Questions:
  • Indication for Induction: Why was induction initiated (e.g., post-term, pre-eclampsia, PROM)? This helps contextualize the risks and benefits of continued induction versus C-section.
  • Method(s) of Induction Used: What cervical ripening agents (e.g., prostaglandins, mechanical dilators) and oxytocin regimen were used? Dosages, duration, and response to each.
  • Membrane Status: Intact or ruptured (spontaneously or artificially)? When was ARM performed?
  • Obstetric History: Parity (gravida/para), previous vaginal deliveries, previous C-sections (indication and type of incision), history of rapid labor, or prolonged labor.
  • Medical Comorbidities: Diabetes, hypertension, obesity, etc.
  • Fetal Assessment: Estimated fetal weight (EFW), presentation, any identified anomalies.
  • Patient's Goals and Preferences: Vaginal birth attempt versus C-section.
• Red Flags:
  • Non-reassuring fetal heart rate (FHR) patterns (e.g., prolonged decelerations, recurrent late decelerations, bradycardia, minimal variability): Requires immediate evaluation and potential intervention.
  • Signs of chorioamnionitis (maternal fever, maternal and/or fetal tachycardia, uterine tenderness, foul-smelling amniotic fluid): May necessitate antibiotics and expedited delivery.
  • Uterine hyperstimulation/tachysystole with non-reassuring FHR: Requires immediate reduction/discontinuation of oxytocin and resuscitative measures.
  • Vaginal bleeding: May indicate placental abruption or vasa previa (especially with rupture of membranes).
  • Patient exhaustion or significant psychological distress.

Laboratory Tests

• First-Line: No specific lab tests directly diagnose failure of induction. Standard labor admission labs:
  • Complete Blood Count (CBC): Assess baseline hemoglobin, hematocrit, and platelet count.
  • Blood Type and Screen: For potential transfusion needs.
  • Urinalysis: To rule out UTI or proteinuria.
• Confirmatory: N/A for the diagnosis of failure of induction itself.
• Monitoring:
  • FHR monitoring: Continuous or intermittent, as per hospital protocol and risk assessment.
  • Contraction monitoring: External to gauge frequency and duration, or internal (IUPC) for objective strength (MVUs).
  • Temperature and vital signs: To monitor for infection or other maternal complications.

Imaging

• Recommended:
  • Ultrasound: If not recently performed, or if there's concern for fetal size or position. Can confirm:
    • Fetal presentation (cephalic, breech).
    • Estimated fetal weight (EFW) and growth concerns (e.g., macrosomia).
    • Amniotic fluid volume.
    • Placental location (if concern for previa).
• Advanced:
  • Pelvimetry (CT or MRI): Rarely indicated for routine management of labor. Its utility in predicting success or failure is limited, as the dynamic nature of labor and molding of the fetal head often overcome subtle pelvic limitations. May be considered in very select cases of suspected severe bony disproportion if clinical suspicion is high and a trial of labor is being considered, but usually a diagnosis of exclusion after a failed trial of labor.

Management

Management of failed induction hinges on carefully defined criteria for failure and balancing the risks of continued induction against the risks of Cesarean delivery.

Acute Management

• Immediate:
  1. Re-evaluate Diagnosis: Ensure an adequate trial has indeed occurred per ACOG/SMFM criteria (e.g., sufficient time on oxytocin, appropriate cervical ripening attempts).
  2. Maternal and Fetal Assessment: Assess maternal vital signs, comfort, and fetal well-being (FHR patterns, reactivity).
  3. Rule out Contributing Factors: Re-assess cervical status (dilation, effacement, station, Bishop score), fetal presentation/position, and uterine activity.
• Stabilization:
  1. Optimize Uterine Activity:
     • If not already done, consider Amniotomy (Artificial Rupture of Membranes - ARM): If the cervix is sufficiently favorable (e.g., ≥ 3-4 cm dilated and effaced) and the fetal head is engaged. ARM can augment labor, improve uterine contractions, and allow direct monitoring via IUPC if needed.
     • Oxytocin Titration: Ensure oxytocin is at an adequate dose and has been given for a sufficient duration. High-dose oxytocin protocols (e.g., starting at 6 mU/min, increasing by 3-6 mU/min every 15-30 min) can be more effective than low-dose protocols in achieving labor. Maximize to the highest safe dose (e.g., 20-40 mU/min) while monitoring for tachysystole and FHR changes.
  2. Repositioning: If malposition is suspected, encourage maternal position changes (e.g., side-lying, hands-and-knees) to encourage fetal rotation and descent.
  3. Supportive Care: Provide adequate hydration, pain management (epidural, if desired), and emotional support to the patient and family.
• Emergency:
  • Non-reassuring Fetal Status: If FHR patterns become non-reassuring (e.g., prolonged deceleration, severe variable decelerations, bradycardia) despite resuscitative measures (oxytocin reduction, IV fluids, oxygen, repositioning), immediate Cesarean delivery is indicated.
  • Signs of Uterine Rupture: Acute severe abdominal pain, sudden FHR decelerations, loss of uterine tone, vaginal bleeding, maternal shock. This is a rare but life-threatening emergency requiring immediate operative delivery.

Chronic Management

Chronic management is not applicable to "failure of induction," as it is an acute obstetric event leading to delivery. However, counseling for future pregnancies regarding risks of repeat induction, C-section, and inter-pregnancy intervals is part of comprehensive care.

Treatment Algorithms

The management algorithm for failure of induction largely involves a structured progression toward either successful vaginal delivery or Cesarean delivery.

• First-Line (Continue Induction Attempt based on ACOG/SMFM Guidelines):
  1. Cervical Ripening: If Bishop score <6, initiate cervical ripening using pharmacological agents (e.g., misoprostol 25 mcg vaginally every 3-6 hours, dinoprostone inserts/gels) or mechanical methods (e.g., Foley balloon catheter). Continue until cervix is favorable or patient enters active labor.
  2. Oxytocin Augmentation: Once cervix is favorable or ripening is complete, or if membranes are ruptured, initiate oxytocin.
     • Protocol: Start low (e.g., 1-2 mU/min) and titrate up (e.g., by 1-2 mU/min every 15-30 min) or use a high-dose protocol (e.g., start 6 mU/min, increase by 3-6 mU/min every 15-30 min) until effective contractions (3-5 contractions in 10 minutes, lasting 40-60 seconds, or >200 MVUs) are achieved.
     • Amniotomy: Consider ARM if the cervix is favorable (e.g., ≥3-4 cm) and the fetal head is engaged, to potentially shorten labor and allow IUPC placement.
  3. Adequate Time Trial: Allow sufficient time for the induction to work before declaring failure:
     • After cervical ripening and before ARM: Allow at least 12-18 hours of oxytocin.
     • After ARM: Allow at least 12-18 hours of oxytocin with adequate contractions before diagnosing active phase arrest, and therefore overall failed induction if active labor was never achieved.
     • Overall: Total induction process (ripening + oxytocin) may last 24-48 hours.
• Second-Line (Decision for Cesarean Delivery):
  • If, after an adequate trial as defined above, the patient has not achieved active labor or has arrested in the latent phase (failure to progress despite maximal efforts and time), Cesarean delivery is indicated.
• Refractory Cases:
  • Failure of induction is the refractory case. The "treatment" for a truly failed induction, once criteria are met, is Cesarean delivery. Continuing induction beyond established guidelines without any signs of progress offers no benefit and increases maternal and fetal risks.

Complications

Common

• Cesarean Delivery: The most frequent outcome of a failed induction, carrying its own risks (infection, hemorrhage, longer recovery).
• Chorioamnionitis/Endometritis: Increased risk due to prolonged rupture of membranes, multiple vaginal exams, and extended labor duration.
• Postpartum Hemorrhage (PPH): Increased risk due to uterine atony (from prolonged labor, high oxytocin doses), C-section, or infection.
• Maternal Fatigue and Emotional Distress: Prolonged labor and failed induction can be physically and psychologically taxing for the mother.

Serious

• Uterine Rupture: A rare but catastrophic complication, particularly in women with a prior uterine scar (e.g., previous C-section) attempting induction, or with excessive oxytocin and hyperstimulation.
• Severe Postpartum Hemorrhage: May require blood transfusion, uterine artery embolization, or even hysterectomy.
• Maternal Sepsis: From untreated chorioamnionitis.
• Fetal Hypoxia/Acidosis: Due to prolonged labor, uterine hyperstimulation, or cord compression, leading to adverse neonatal outcomes (e.g., HIE, NICU admission).

Long-term

• Future Pregnancy Complications: A C-section for failed induction increases the risk of complications in subsequent pregnancies, including:
  • Increased risk of repeat C-section.
  • Placenta previa and placenta accreta spectrum disorders in subsequent pregnancies.
  • Increased risk of uterine rupture in future trials of labor after C-section (TOLAC).
• Psychological Impact: Some women may experience disappointment, grief, or even trauma related to a failed induction and unexpected C-section.

Prognosis

Factors

• Bishop Score: The most significant predictor. A higher Bishop score (≥8) dramatically increases the success rate of induction.
• Parity: Multiparous women have a significantly higher success rate.
• Body Mass Index (BMI): Higher BMI is associated with lower success rates.
• Gestational Age: Induction success rates tend to increase with advancing gestation until 41-42 weeks.
• Reason for Induction: Some indications (e.g., post-term) may have better success rates than others (e.g., intrauterine growth restriction).
• Fetal Characteristics: Macrosomia and malposition decrease success.
• Adequacy of Induction Protocol: Sufficient time and appropriate dosing of agents.

Survival

• Maternal Survival: Excellent, though morbidity is increased compared to successful vaginal delivery.
• Fetal Survival: Excellent in the absence of severe complications (e.g., uterine rupture or severe fetal distress leading to uncorrected hypoxia). The majority of neonates are born healthy.

Quality of Life

• Short-term: C-section recovery involves more pain, longer hospital stay, and delayed return to normal activities compared to uncomplicated vaginal birth. Increased risk of pain and discomfort from surgical incision.
• Long-term: Most women recover well. However, the psychological impact of a failed induction and unexpected C-section can persist, affecting future reproductive decisions and potentially contributing to anxiety or depression.

Prevention

Primary

• Careful Patient Selection: Ensure there is a valid medical indication for induction. Avoid elective inductions in nulliparous women with unfavorable cervices, especially before 39 weeks.
• Cervical Ripening: Prioritize effective cervical ripening strategies (prostaglandins, mechanical dilators) in women with an unfavorable cervix. Adequate ripening is the cornerstone of successful induction.
• Education and Counseling: Thoroughly counsel patients on the induction process, potential duration, and realistic success rates, including the possibility of C-section.
• Antenatal Care: Optimizing maternal health (e.g., glucose control in diabetes, blood pressure control in hypertension) can mitigate some risk factors.

Secondary

• Prolonged Latent Phase Management: Do not diagnose failed induction prematurely. Allow adequate time (12-18 hours or more of oxytocin with ruptured membranes, potentially up to 24-48 hours overall induction) to assess true failure, especially in nulliparous women.
• Aggressive but Safe Oxytocin Titration: Utilize high-dose oxytocin protocols to achieve effective uterine contractions, while diligently monitoring for uterine tachysystole and FHR changes.
• Early Amniotomy: When appropriate, performing ARM can accelerate labor once the cervix is ripe enough.
• Continuous Monitoring: Vigilant monitoring of maternal-fetal well-being throughout the induction process.

Tertiary

• Early Recognition of Failure: Identify non-progressing labor and intervene with Cesarean delivery in a timely manner to prevent severe maternal and fetal complications (e.g., prolonged labor leading to exhaustion, infection, fetal distress, uterine rupture).
• Postpartum Care: Implement strategies to prevent common complications like PPH (e.g., active management of third stage of labor, oxytocin administration).
• Debriefing: Provide opportunities for patients to discuss their labor experience, especially if it was prolonged or resulted in an unexpected C-section, to help process emotions and reduce psychological distress.

Special Populations

• Pregnancy with Prior Cesarean Section (TOLAC):
  • Induction in TOLAC candidates carries a higher risk of uterine rupture and lower success rates compared to spontaneous labor.
  • Mechanical methods (Foley balloon) are generally preferred over prostaglandin agents (especially misoprostol, which is contraindicated) for cervical ripening due to a lower risk of uterine rupture.
  • Oxytocin use should be cautious, with vigilant monitoring for signs of rupture.
  • The threshold for diagnosing failed induction and proceeding to repeat C-section might be lower due to the increased risk associated with prolonged labor in this group.
• Obese Patients:
  • Higher rates of failed induction.
  • May require higher oxytocin doses and longer induction times.
  • Challenges with external fetal monitoring may necessitate earlier use of internal monitoring (IUPC) to accurately assess contraction strength.
  • Increased risk of C-section complications (infection, wound complications, PPH).
• Patients with Pre-eclampsia/Hypertension:
  • Often induced for maternal indications.
  • Close monitoring of blood pressure, fluid status, and fetal well-being is paramount.
  • The need for expeditious delivery due to maternal condition may influence the duration of the induction attempt.
• Patients with Diabetes (especially with suspected macrosomia):
  • Increased risk of failed induction due to potential macrosomia leading to CPD or malposition.
  • Careful fetal weight estimation via ultrasound is important.
  • Increased risk of shoulder dystocia if vaginal delivery is attempted with a very large fetus.

Clinical Pearls

Diagnostic

• "Time is Cervix": The most common mistake in diagnosing failed induction is insufficient time. Ensure that the patient has received an adequate trial of both cervical ripening and oxytocin, according to ACOG/SMFM guidelines. Patience is key, especially in nulliparous women.
• Objective Assessment: Rely on objective measures: Bishop score for ripeness, Montevideo Units (MVUs) from IUPC for contraction strength, and cervical exams for change. Subjective assessment of contractions can be misleading.
• Re-evaluate Fetal Position: If progress stalls, always re-evaluate fetal position and station. A persistent occiput posterior or transverse position can impede progress despite adequate contractions.

Treatment

• Maximize Oxytocin Safely: Don't hesitate to titrate oxytocin to maximum safe doses to achieve effective contractions (e.g., >200 MVUs).
• Consider Amniotomy Early (when indicated): If the cervix is favorable and the head is engaged, ARM can be a powerful tool to accelerate labor and allow direct assessment of uterine activity with an IUPC.
• Fluid and Comfort: Ensure the laboring patient is well-hydrated and comfortable. Pain and dehydration can inhibit labor progress. Epidural analgesia, when requested, does not increase the risk of failed induction and can improve patient comfort.

Pitfalls

• Premature Diagnosis of Failure: Cutting the induction short based on arbitrary time limits or impatient assessment, leading to unnecessary Cesarean deliveries.
• Inadequate Cervical Ripening: Skipping or insufficient cervical ripening when starting with an unfavorable cervix, setting the stage for failure.
• Misinterpreting Contractions: Relying solely on external monitoring, which can overestimate or underestimate true contraction strength. Use IUPC if there's doubt about uterine activity and progress is stalled.
• Ignoring Malposition: Not considering fetal malposition as a cause for lack of progress and failing to encourage position changes.
• Fear of High-Dose Oxytocin: Under-dosing oxytocin for fear of hyperstimulation, when careful titration with continuous monitoring is safe and effective.

Recent Updates

Guidelines

• ACOG Practice Bulletin No. 205 (December 2018, Reaffirmed 2021), "Labor Induction": This is the definitive guideline providing criteria for failed induction, recommended induction methods, and duration of induction attempts. Key takeaway: Allow sufficient time for an adequate trial, often extending beyond 12-18 hours of active oxytocin.
• SMFM Consult Series #33 (March 2016), "Trial of Labor After Cesarean": Provides guidance on induction methods and timing in TOLAC candidates, where specific precautions and different considerations apply regarding failed induction.

Evidence

• Recent research continues to support longer induction durations, particularly for nulliparous women with unfavorable cervices. Studies have shown that extending the latent phase or allowing for 24-48 hours of induction efforts significantly reduces the Cesarean rate without increasing maternal or neonatal morbidity.
• Comparative studies on cervical ripening methods show that both prostaglandin E1 (misoprostol) and mechanical methods (Foley catheter) are effective, with mechanical methods potentially having a slightly lower risk of uterine hyperstimulation. The choice often depends on clinical scenario and contraindications.
• Studies on high-dose versus low-dose oxytocin protocols generally show that higher doses lead to shorter labors without significantly increasing risks, provided monitoring is vigilant.

Controversies

• Optimal Duration of Induction: While guidelines suggest extended durations, the exact cut-off for "failure" remains a topic of debate, with some clinicians advocating for even longer trials in highly selected cases. Balancing the desire for vaginal birth with maternal and fetal safety is crucial.
• Role of Amniotomy: The optimal timing of amniotomy during induction remains debated. While it can shorten labor, performing it too early with an unengaged head can increase the risk of cord prolapse.
• Induction in TOLAC: Balancing the desire for TOLAC with the increased risk of uterine rupture, especially with induction, continues to be a challenging area.

Key References

• ACOG Practice Bulletin No. 205: Labor Induction. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2018 Dec;132(6):e208-e219. Reaffirmed 2021.
• SMFM Consult Series #33: Trial of Labor After Cesarean. Society for Maternal-Fetal Medicine. Am J Obstet Gynecol. 2016 Mar;214(3):B2-B13.
• Obstetrics: Normal and Problem Pregnancies. Gabbe, Steven G., et al. (Current Edition). Elsevier. (Comprehensive textbook covering labor and delivery management).
• Williams Obstetrics. Cunningham, F. Gary, et al. (Current Edition). McGraw-Hill Education. (Another highly respected and comprehensive textbook).
• Monitoring of Labor Toolkit. World Health Organization (WHO). (Provides practical guidance on labor progress monitoring and management).